Role of CRF1 and CRF2 receptors in fear and anxiety

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 7-8, 2001, Pages 627-636

  Takahashi, Lorey K ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Anxiety; Corticotropin releasing factor; CRF receptor antagonists; CRF1 receptor; CRF2 receptor; Fear; Spontaneous anxiety; Stress; Stress induced anxiety

Indexed keywords

2 [N (2 BROMO 4 ISOPROPYLPHENYL) N ETHYLAMINO] 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 6 METHYLPYRIMIDINE; 3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; ANTALARMIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DPC 904; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANXIETY; ARTICLE; DRUG EFFECT; EMOTIONALITY; FEAR; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOLOGIC TEST; RECEPTOR DENSITY; STRESS; TRANQUILIZING ACTIVITY;

EID: 0035712779     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(01)00046-X     Document Type: Short Survey

References (82)

1. The effects of stressful life events on depression
2. Schizophrenia: A neural diathesis-stress model
3. The effects of neonatal stress on brain development: Implications for psychopathology
4. Prenatal stress: Consequences of glucocorticoids on hippocampal development and function
5. Allostasis and allostatic load: Implications for neuropsychopharmacology
6. Regulation of autonomic nervous suystem by corticotropin-releasing factor
7. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
8. The role of corticotropin-releasing factor in behavioural responses to stress
9. Role of corticotropin-releasing factor in mediating the expression of defensive behavior
10. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and α-endorphin
11. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochemical study
12. Distribution of wocortin-like immunoreactivity in the central nervous system of the rat
13. Organization of CRF immunoreactive cells and fibers in the rat brain: Immunohistochemical studies
14. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study
15. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
16. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
17. Expression cloning of a human corticotropin-releasing-factor receptor
18. Primary structure and functional expression of mouse pituitary and human brain CRF receptors
19. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
20. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart
21. 2γ receptor
22. Molecular biology of CRH receptor - In the mood
23. Corticotropin-releasing factor receptors: An overview
24. 1 receptor mRNA expression
25. 2 binding sites in adult rat brain
26. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain
27. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues
28. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF
29. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response
30. Stress, corticotropin-releasing factor, and drug addiction
31. Cardiovascular actions of CRH and urocortin: An update
32. Corticotropin-releasing hormone receptor subtypes and emotion
33. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: Role of brain corticotropin-releasing factor receptors
34. Corticotropin-releasing factor receptor antagonists
35. Integration of molecular biological techniques and behavioral pharmacology
36. Antisense oligonucleotides: Promise and reality
37. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1
38. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
39. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
40. 2, receptors mediate anxiogenic-like behavior
41. Corticotropin-releasing hormone receptor (Type I) antisense targeting reduces anxiety
42. Differential behavioural effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain
43. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats
44. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
45. Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
46. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone
47. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity
48. 1 receptor antagonist
49. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
50. 1 receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups
51. Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats
52. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
53. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat
54. Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus)
55. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation
56. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
57. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine and autonomic responses to stress in primates
58. 1 receptor antagonists, CRA1000 and CRA1001
59. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats
60. 1) antagonist
61. The anxiolytic effect of CRH1 receptor antagonist R121919 depends on innate emotionality in rats
62. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor
63. Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior
64. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
65. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
66. The role of the amygdala in fear and anxiety
67. Amygdaloid contributions to conditioning arousal and sensory information processing
68. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear
69. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala and hypothalamic paraventricular nucleus: An in situ hybridization analysis
70. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior
71. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
72. Low doses of muscimol produce anticonflict actions in the lateral septum of the rat
73. The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam
74. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
75. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2β-selective antisauvagine-30
76. 125I-antisauvagine-30: A novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors
77. 2 receptors produces anxiolytic behavior in animal models of anxiety
78. Genetics of mouse behavior: Interactions with laboratory environment
79. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
80. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
81. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor